Keyphrases
Progressive multiple Sclerosis
77%
Dimethyl Fumarate
66%
Multiple Sclerosis
51%
Relapsing-remitting multiple Sclerosis
44%
Intrathecal
33%
Progressive MS
31%
Follicular Helper T Cells
26%
Neurofilament Light (NF-L)
26%
Cognitive Function
24%
B Cells
23%
T Cells
16%
Multiple Sclerosis Treatment
15%
Randomized Controlled Trial
15%
Placebo
14%
Disease Severity
14%
CD20+ T Cells
13%
Migration Potential
13%
Alemtuzumab
13%
Quality of Life
13%
Tph Cells
12%
Peripheral Helper T Cells
12%
Natalizumab Treatment
12%
Immunological Effects
12%
Open-label Extension
12%
Memory T Cells
12%
Relapse Risk
12%
MAIT Cells
12%
CD8+
12%
Tumefactive multiple Sclerosis
12%
Cannabidiol
12%
Tfh Cells
12%
Placebo-controlled Trial
12%
Immune Reconstitution
12%
Neuropathic Pain
12%
Exhausted T Cells
12%
Cerebrospinal Fluid Biomarkers
12%
Regulatory Control
12%
Cannabis-based Medicine
12%
Cell Control
12%
Lipoprotein Receptor-related Protein
12%
Cell Subtypes
12%
Gene Variation
12%
Inflammatory Biomarkers
12%
Spasticity
12%
B Cell Response
12%
Cardiovascular Risk
12%
Tissue Damage
12%
Cognitive Qualities
12%
Function Structure
12%
Brain Structure
12%
Neuroscience
Multiple Sclerosis
100%
Primary Progressive Multiple Sclerosis
71%
T Cell
65%
Relapsing Remitting Multiple Sclerosis
44%
Intrathecal
44%
Placebo
41%
Neurofilament Light Chain
37%
Magnetic Resonance Imaging
25%
Cognitive Function
24%
B Cell
17%
Randomized Controlled Trial
17%
CD8
15%
Flow Cytometry
13%
Myelin Basic Protein
12%
CD20
12%
Lipoprotein Receptor-Related Protein
12%
Natalizumab
12%
Neuropathic Pain
12%
Cannabis
12%
Expanded Disability Status Scale
11%
Nabiximols
10%
CD4
9%
Central Nervous System
9%
Cannabidiol
8%
Spinal Cord Injury
8%
Tetrahydrocannabinol
8%
Magnetization Transfer
7%
California Verbal Learning Test
6%
Interleukin 7
5%
Medicine and Dentistry
Multiple Sclerosis
80%
Fumaric Acid Dimethyl Ester
40%
Placebo
28%
Randomized Controlled Trial
24%
Light Chain
14%
Neurofilament
14%
CD20
12%
T Follicular Helper Cell
12%
Medicine
12%
Lipoprotein Receptor
12%
Cognition
12%
Disease Severity
12%
CD8 Antigen
12%
Cardiovascular Risk
12%
B Cell
12%
Spasticity
12%
T Cell
12%
Cannabis
12%
Neuropathic Pain
12%
Magnetic Resonance Imaging
11%
Nabiximols
8%
Cannabidiol
7%
Spinal Cord Injury
7%
Tetrahydrocannabinol
7%
Symptom
6%
Resistance Training
6%
Symbol Digit Modalities Test
5%